Search results
New pathways for treating never-smoker lung cancer revealed
Medical Xpress· 2 days agoThe primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via AOL· 6 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
Pfizer drug extends life for people with rare form of lung cancer
AFP via Yahoo News· 6 days agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
Hypoxemia due to sleep apnea is associated with risk of lung cancer reoccurrence
Medical Xpress· 1 day agoResults show that a 4% oxygen desaturation index of more than 15 and time spent in desaturation...
Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery
Tehachapi News· 3 days agoThe transformative approach to genomic sequencing yields the first validated high-sensitivity lung cancer screening test that could close gaps in screening ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 6 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoUse (CHMP) of the European Medicines Agency (EMA) has recommended approving AstraZeneca's Tagrisso,...
Does Palliative Care via Telehealth Work in Advanced Cancer?
Medscape· 3 days agoEarly palliative care can be delivered successfully and efficiently using telehealth in patients...
Oral insulin drops offer relief for diabetes patients
Medical Xpress· 8 hours agoResearchers at the Li Lab have developed oral insulin drops that—when placed under the tongue—are...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 3 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...